ARCHIVES

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

February 24, 1989

Chemo Combinations Tested In Phase III For Lung Cancer

August 31, 2001

Low Total Cholesterol Linked To Higher Risk Of Cancer; Higher HDL Associated With Decreased Risk Of Cancer

November 27, 2009

Sacharin Issue Splits Scientists; ACS Proposes Delaney Changes

April 15, 1977

Study: HPV Testing Can Predict Precancers For Nearly Two Decades Following Exam

August 31, 2012

Afinitor Extends PFS In Women With EGFR-2 Positive Disease

June 28, 2013